Lead Product(s) : Pentostatin
Therapeutic Area : Oncology
Study Phase : Phase II
Sponsor : Regione Lombardia | GSK | Pfizer Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Pentostatin is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Leukemia, Lymphocytic, Chronic, B-Cell.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 10, 2012
Lead Product(s) : Pentostatin
Therapeutic Area : Oncology
Highest Development Status : Phase II
Sponsor : Regione Lombardia | GSK | Pfizer Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
